التهاب الكبد الفيروسي (أ): الملف الوبائي, السريري و حالات المرضى بعد العلاج في مستشفى حماية الاطفال التعليمي / مدينة الطب و ضرورة  وضع برنامج لقاحي له.

1. Odenwald MA, Paul S. Viral hepatitis: Past, present, and future. World J Gastroenterol. 2022 Apr 14;2814):1405-1429.PMID: 35582678; PMCID: PMC9048475.Hollinger FB, Liang TJ. Hepatitis B virus. Fields virology. Lippincott Williams & Wilkins, Philadelphia. 2017:2971-3036.https://doi.org/10.3748/wjg.v28.i14.1405.

2. Abutaleb A, Kottilil S. Hepatitis A: Epidemiology, Natural History, Unusual Clinical Manifestations, and Prevention. GastroenterolClin North Am. 2020 Jun;492):191-199. Epub 2020 Mar 29. PMID: 32389358;PMCID:PMC7883407.https://doi.org/10.1016/j.gtc.2020.01.002.

3. Aggarwal R, Goel A. Hepatitis E: current status in India. Clin Liver Dis

Hoboken). 2021;183):168-172. https://doi.org/10.1002/cld.1040PMid:33163170 PMCid:PMC7609704

4. Pérez-Sautu U, Costafreda MI, Caylà J, Tortajada C, Lite J, Bosch A, Pintó RM. Hepatitis a virus vaccine escape variants and potential new serotype emergence. Emerg Infect Dis. 2011 Apr;174):734-7. Https://doi.org/10.3201/eid1704.101169. PMID: 21470474; PMCID: PMC3377408.

5. Nelson NP, Weng MK, Hofmeister MG, Moore KL, Doshani M, Kamili S, Koneru A, Byrd KK. Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020. MMWR Recomm Rep. 2020;69No. RR-5):1-38. https://doi.org/10.15585/mmwr.rr6905a1.

PMid:32614811 PMCid:PMC8631741

6. Gabrielli F, Alberti F, Russo C, Cursaro C, Seferi H, Margotti M, Andreone P. Treatment Options for Hepatitis A and E: A Non-Systematic Review. Viruses. 2023 Apr 28;155):1080. Https://doi.org/10.3390/v15051080. PMID: 37243166; PMCID: PMC10221699.

7. UFallucca A, Restivo V, Sgariglia MC, Roveta M, Trucchi C. Hepatitis a Vaccine as Opportunity of Primary Prevention for Food Handlers: A Narrative Review. Vaccines Basel). 2023 Jul 21;117):1271. Https://doi.org/10.3390/vaccines11071271. PMID: 37515087; PMCID: PMC10383099.

8. Dhawan A, Cheeseman P, Mieli-Vergani G. Approaches to acute liver failure in children. Pediatr Transplant. 2020;244):e13678.https://doi.org/10.1111/petr.13678 PMid:32343885

Castaneda D, Gonzalez AJ, Alomari M, Tandon K, Zervos XB. From hepatitis A to E: A critical review of viral hepatitis. World J Gastroenterol. 2021 Apr 28;2716):1691-1715. Https://doi.org/10.3748/wjg.v27.i16.1691. PMID: 33967551; PMCID: PMC8072198.

9. Migueres M, Lhomme S, Izopet J. Hepatitis A: Epidemiology, High-Risk Groups, Prevention and Research on Antiviral Treatment. Viruses. 2021;1310):1900. doi:10.3390/v13101900 https://doi.org/10.3390/v13101900

PMid:34696330 PMCid:PMC8540458

10. Langan RC, Goodbred AJ. Hepatitis A. Am Fam Physician. 2021 Oct 1;1044):368-374. PMID: 34652109.

11. Zhang L. Hepatitis A vaccination. Hum VaccinImmunother. 2020 Jul 2;167):1565-1573. Epub 2020 Jul 10. PMID: 32649265; PMCID: PMC7482852.https://doi.org/10.1080/21645515.2020.1769389

12. Abu-Raddad LJ, Ayoub HH, Chemaitelly H, Mumtaz GR, Butt AA, May MT, Hallett TB. Characterizing the Epidemiology of Hepatitis A in the Middle East and North Africa: Implications for Vaccination Strategies. Journal of Infection and Public Health. 2021;144):409-420.

https://doi.org/10.1016/j.jiph.2021.01.002PMid:33743368PMCid:PMC7834000

13. Badur S, Öztürk S, Ozakay A, Khalaf M, Saha D, Van Damme P. A review of the experience of childhood hepatitis A vaccination in Saudi Arabia and Turkey: implications for hepatitis A control and prevention in the Middle East and North African region. Human Vaccines &Immunotherapeutics. 2021 Oct 3;1710):3710- 28. https://doi.org/10.1080/21645515.2021.1920871

PMid:34213403 PMCid:PMC8437515

14. Foster MA, Hofmeister MG, Xing J, et al. Declining hepatitis A mortality in the United States during the era of hepatitis A vaccination. Journal of Infectious Diseases. 2021;2239):1450-1459. https://doi.org/10.1093/infdis/jiab046

PMid:35238363 PMCid:PMC8892529

15. Chicago Department of Public Health. Hepatitis A Response and Immunization Program. *Chicago Health Reports*. 2021;Issue 7:45-50. Available at:https://www.chicagohan.org/documents/14171/93622/Hepatitis_A_10242017

16. Centers for Disease Control and Prevention CDC). Hepatitis A Surveillance Report. *CDC Annual Reports*. 2021. Available at: https://www.cdc.gov/hepatitis/statistics/2021surveillance/hepatitis-a.htm

17. Hussein HK. Three years epidemiological study of acute hepatitis A infection in Al Elwyia pediatric teaching hospital, Baghdad, Iraq. Rawal Medical Journal. 2019 Oct 8;443):436-.

18. Daood II, RH I. Seroprevalence of Hepatitis A Virus HAV) in Mosul City. Medico Legal Update. 2020 Jan;201):310-4.

19. AA Darwish L, Nasrallah AA, Al Mousaw A. Hepatitis A in Kerbala: Eight Year Epidemiological Study. Kerbala Journal of Medicine. 2018 Jun 1;111):3873-83.

20. Akman AÖ, Burhan BY, Uzun AK, Taş D. Hepatitis A virus age-specific seroprevalence after the implementation of a Toddlers' Vaccination in Turkey: Shifting susceptibility to adolescents. Turk PediatriArs. 2020 Dec 16;554):370-375. https://doi.org/10.1016/j.sbspro.2011.05.114PMID: 33414654; PMCID: PMC7750331.

21. Elsabawy MN. Hepatitis gender gap in Egypt: A study in medical geography. Procedia-Social and Behavioral Sciences. 2018 Jan 1;19:121-30.https://doi.org/10.1016/j.sbspro.2011.05.114.

22. Choe YJ, Son H. The changing gender differences in hepatitis a incidence in South Korea. Vaccine. 2020 Jan 22;384):712-4. https://doi.org/10.1016/j.vaccine.2019.11.048

PMid:31787416

23. Cao G, Jing W, Liu J, Liu M. The global trends and regional differences in incidence and mortality of hepatitis A from 1990 to 2019 and implications for its prevention. Hepatol Int. 2021 Oct;155):1068-1082.. Epub 2021 Aug 3. PMID: 34345993; PMCID: PMC8514357.https://doi.org/10.1007/s12072-021-10232-4

24. Abdullah I; Goreal A. Seroprevalence of anti-hepatitis A virus antibody in Iraq. East Mediterr Health J. 2022;2811):829–834. https://doi.org/10.26719/emhj.22.087

25. Tong MJ, el-Farra NS, Grew MI. Clinical manifestations of hepatitis A: recent experience in a community teaching hospital. J Infect Dis. 1995 Mar;171Supplement_ 1:S15-8. https://doi.org/10.1007/s12072-021-10232-4. PMID: 7876641.

26. Arooj S, Mukhtar MU, Abbas F. An acute viral hepatitis epidemic: does ultrasound help the pediatrician? BMC Res Notes. 2021 Mar 10;141):95. https://doi.org/10.1186/s13104-021-05510-1. PMID: 33691769; PMCID: PMC7944630.

27. Han HS, Park CM, Lee DS, Sinn DH, Gil E. Evaluating mortality and recovery of extreme hyperbilirubinemia in critically ill patients by phasing the peak bilirubin level: A retrospective cohort study. PLoS One. 2021Aug5;168):e0255230. https://doi.org/10.1371/journal.pone.0255230. PMID: 34351969; PMCID: PMC8341602.

28. Jiang AA, Greenwald HS, Sheikh L, Wooten DA, Malhotra A, Schooley RT, Sweeney DA. Predictors of acute liver failure in patients with acute hepatitis A: an analysis of the 2016-2018 San Diego county hepatitis A outbreak. InOpen forum infectious-diseases 2019 Nov Vol. 6, No. 11, p. ofz467). US: Oxford University Press. https://doi.org/10.1093/ofid/ofz467 PMid:31777757 PMCid:PMC6868431

29. Anand AC, Nandi B, Acharya SK, et al. Indian National Association for the Study of the Liver Consensus Statement on Acute Liver Failure Part 1): Epidemiology, Pathogenesis, Presentation and Prognosis. J Clin Exp Hepatol. 2020 Jul-Aug;104):339-376. Epub 2020 Apr 28. PMID: 32655238; PMCID: PMC7335721.https://doi.org/10.1016/j.jceh.2020.04.012

30. van Lennep M, Leijdekkers ML, Oors JM, Benninga MA, van Wijk MP, Singendonk MM. Clinical experience with performing esophageal function testing in children. Journal of pediatric gastroenterology and nutrition. 2021 Feb1;722):226-31. https://doi.org/10.1097/MPG.0000000000003000

PMid:33230070 PMCid:PMC7815250

31. Hrynkiewicz R, Niedźwiedzka-Rystwej P. Etiology of viral induced acute liver failure and defensins as potential therapeutic agents in ALF treatment. Front Immunol. 2023 Apr 21;14:1153528. doi: 10.3389/fimmu.2023.1153528. PMID: 37153560; PMCID:PMC10160486.https://doi.org/10.3389/fimmu.2023.1153528

PMid:37153560 PMCid:PMC10160486

32. Naher B, Islam R, Ghosal S, Nahid KL. Rukunuzzaman 2021) Seroprevalence and Co-infection of Hepatitis A and Hepatitis E Viruses in children-A hospital-based study in Bangladesh. J NeonatolClinPediatr 8: 080. of.;4:2.

33. Escobedo-Meléndez G, Fierro NA, Roman S, Maldonado-González M, Zepeda-Carrillo E, Panduro A. Prevalence of hepatitis A, B and C serological markers in children from western Mexico. ANNALS of Hepatology. 2012 Mar

34. https://doi.org/10.1016/S1665-268119)31024-5.

35. Kanda T, Sasaki R. Hepatitis A Infection in Patients with Chronic Liver Disease: Clinical Outcomes and Management. *Int J Mol Sci*. 2022;233):1267. https://doi.org/10.3390/ijms23031267

PMid:35163190 PMCid:PMC8836203

36. Thejeal RF, Abdulwahhab SB, Bahlol AR. Epidemiological study of hepatitis A infection, experience of children welfare teaching hospital: One-year analysis. EurAsian Journal of BioSciences. 2020 Aug 1;142): 6673-6677

37. Hofmeister MG, Xing J, Foster MA, et al. Hepatitis A person-to-person outbreaks: epidemiology, morbidity burden, and factors associated with hospitalization—multiple states, 2016–2019. J Infect Dis. 2021 Feb 1;2233):426-34. https://doi.org/10.1093/infdis/jiaa636